Genzyme Center, Cambridge, 02142, USA
- Sanofi-Genzyme BioVentures (SGBV) is the corporate venture capital arm of Sanofi. Previously known as Genzyme Ventures, SGBV has a recently expanded mandate to invest across the more expansive business footprint of Sanofi. SGBV is an important component of Sanofi’s broader global strategy to invigorate external innovation and research. SGBV only invests in early stage companies with promising new products that may be future Sanofi pipeline candidates.
There is much more to this profile.
Log in or sign up for free to see the whole thing.
Get free access to these powerful tools:
- Advanced search filters
- Full startup and investor profiles
- Follow startups and investors
- Custom follow-lists
- Startup benchmarking
- Network maps
- Market stats